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1
Problem Identification
 In 2015, 48% of dispensed controlled substances in VT were opioids.  Although the 
total number of prescriptions have increased since 2010, the total number of 
recipients has decreased.2
 Prescriptions of opioids for MAT and to treat pain has increased since 2010, with 
analgesics covering 78% of opioid prescriptions.2
 In Windham County, 28% of county residents were prescribed opioids in 2015.2
 In 2015, of the 55 Vermont deaths involving prescription opioids, 4  were related 
to poisonings involving both benzodiazepine and a prescription opioid.3
 CDC considers individuals with analgesic opioid prescriptions of 90 Morphine 
Milligram Equivalents (MME) are at higher risk for dependence and abuse.4
 In 2015, 81% of opioid related fatalities had received a 90 MME prescription within 
5 years, 36% filled a prescription for 90 MME within one year, 24% filled a 
prescription within 30 days and 20% filled a prescription within 10 days.4
2
Public Health Cost
 National opioid abuse health care costs are estimated to be $25 billion 
annually.1
 In 2014, Pro-rated health care costs for opioid abuse in Vermont were 
estimated to be $38 million, due to Vermont representing 0.2% of the US 
population.1




 Chris McConnell, a Deerfield Valley community member, felt the new 
regulations were needed to combat opioid prescription abuse.  He has 
witnessed others abusing these medications.  Mr. McConnell was especially 
happy about the requirement to prescribe naloxone to treat opioid 
intoxication.
 A Deerfield Valley provider acknowledged the need for tighter control over 
opioid prescriptions and the current crisis within Windham county.  She was 
unsure if new regulations would significantly add to the judiciousness, which 
health center providers follow, in managing and prescribing opioids.  
4
Intervention and Methodology
 New prescriber regulations will add considerable paperwork for providers and 
their medical staff.  As such, everyone within the Deerfield Valley health 
Center should be comfortable with the new regulations before the effective 
date of July 1, 2017
 A power point presentation on new prescriber regulations was made for the 
Deerfield Valley Health Center.  
 This presentation included background to the current opioid crisis as well as 
information on how to calculate morphine equivalents.  
 This presentation is part of a series of information sessions designed to ensure 
compliance to the new regulations.
5
Results/Response
 Thirty minute Power Point presentation given to entire Deerfield staff on June 6, 
2017.
 Health center staff were supportive of the presentation.  They felt an earlier 
presentation from the Vermont Department of Health did not effectively present 
the new law into easy to understand segments.  
 Health Center director reported that the presentation helped in resolving support 
staff fears about additional clerical work required under the new regulations.  
 Health center opioid prescribers thought the presentation could have been more 
technical in regards to the specific Morphine Milligram Equivalent (MME) limits on 
prescribing.  
6
Evaluation of Effectiveness and 
Limitations
 A single presentation cannot adequately answer all staff questions pertaining 
to new regulations.  The various health center professionals require different 
presentations about specific aspects of the new regulations.  
 Include post presentation evaluation sheet to gage effectiveness from the 
audience.
 After the new regulations are implemented on July 1, 2017, schedule a 
meeting to discuss the implementation of new procedures and determine if 
additional questions or concerns remain.  
7
Recommendations for Future Projects
 Reconfigure current opioid prescription informed consent sheet to meet 
specific needs to the Deerfield valley population as well as including 
mandatory information from the State of Vermont.
 Reconfigure current opioid prescription patient information sheet to reflect 
specific needs of the Deerfield Valley population.  
 Help to shape future health center operating procedures to incorporate a 
stepwise process in education staff when new state regulations are enacted.
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